Correspondence to 'dose evaluation for long-term magnesium treatment in aneurysmal subarachnoid haemorrhage'

Journal of Clinical Pharmacy and Therapeutics

Volumn 31, Issue 4, 2006, Pages 407-

  Wong, G K C ^a   Chan, M T V ^a   Boet, R ^a   Poon, W S ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

MAGNESIUM SULFATE;

ABSENCE OF SIDE EFFECTS; BRAIN ARTERY ANEURYSM; BRAIN ISCHEMIA; CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG INFUSION; HUMAN; LETTER; LONG TERM CARE; NEUROPROTECTION; NONHUMAN; PILOT STUDY; SUBARACHNOID HEMORRHAGE;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; HUMANS; INFUSIONS, INTRAVENOUS; MAGNESIUM SULFATE; RATS; SUBARACHNOID HEMORRHAGE;

EID: 33745940916     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2006.00728.x     Document Type: Letter

References (4)

1. van Norden AGW, van den Bergh WM, Rinkel GJE (2005) Dose evaluation for long-term magnesium treatment in aneurysmal subarachnoid haemorrhage. Journal of Clinical Pharmacy and Therapeutics, 30, 439-442.
2. Boet R, Chan MTV, Poon WS, Wong GKC, Wong HT, Gin T (2005) Intravenous magnesium sulphate to improve outcome after aneurysmal subarachnoid haemorrhage. Acta Neurochirurgica, 95, 263-264.
3. Miles AN, Majda BT, Meloni BP, Knuckey NM (2001) Postischemic intravenous administration of magnesium sulphate inhibits hippocampal CA1 neuronal death after transient global ischemia in rats. Neurosurgery, 49, 1450-1451.
4. Westermaier T, Zausinger S, Baethmann A, Schmid-Elsaesser R (2005) Dose finding study of intravenous magnesium sulphate in transient focal cerebral ischemia in rats. Acta Neurochirurgica, 147, 525-532.